Sifuentes-Rodríguez Erika, Palacios-Reyes Deborah
Servicio de Pediatría, Hospital Ángeles Lomas, Instituto Nacional de Pediatría. Mexico City, Mexico.
Servicio de Parasitología y Micología, Instituto Nacional de Pediatría. Mexico City, Mexico.
Bol Med Hosp Infant Mex. 2020;77(2):47-53. doi: 10.24875/BMHIM.20000039.
Before the severe acute respiratory syndrome outbreak in 2003, coronaviruses (CoVs) were not considered to be highly pathogenic to humans. However, it was this epidemic that highlighted this group of viruses and included them among the causative agents of emerging epidemic diseases. In addition, in 2012, another new CoV responsible for the Middle East respiratory syndrome was identified. Both infections were considered a threat to global health security. At present, the third epidemic caused by a CoV is being faced. This new CoV, called 2019-nCoV, was originated in the city of Wuhan, China, and has been linked to severe respiratory infections in humans. Thanks to the collaboration of experts worldwide, more information about this virus and its infection is reported each day, which allows modifying the recommendations for its prevention and treatment, without forgetting that the ultimate goal is to control this epidemic. In this review, the important aspects of this new coronavirus, 2019-nCoV, and its disease, COVID-19, have been summarized with the information available up to February 2020.
在2003年严重急性呼吸综合征爆发之前,冠状病毒(CoVs)并未被认为对人类具有高度致病性。然而,正是这场疫情凸显了这类病毒,并将它们纳入新兴传染病的病原体之中。此外,2012年,另一种导致中东呼吸综合征的新型冠状病毒被发现。这两种感染都被视为对全球卫生安全的威胁。目前,正面临由冠状病毒引发的第三次疫情。这种名为2019-nCoV的新型冠状病毒起源于中国武汉市,并与人类严重呼吸道感染有关。得益于全球专家的合作,每天都有更多关于这种病毒及其感染情况的信息被报道,这使得针对其预防和治疗的建议得以修改,同时不要忘记最终目标是控制这场疫情。在本综述中,已根据截至2020年2月的现有信息,总结了这种新型冠状病毒2019-nCoV及其疾病COVID-19的重要方面。